Advances of Nano Drug Delivery System for the Theranostics of Ischemic Stroke

Overview

Journal J Nanobiotechnology

Publisher Biomed Central

Specialty Biotechnology

Date 2022 Jun 1

PMID 35641956

Authors

Wei Lv

Yijiao Liu

Shengnan Li

Lingyan Lv

Hongdan Lu

Hongliang Xin

Affiliations

Soon will be listed here.

Abstract

From the global perspective, stroke refers to a highly common cause of disability and death. Ischemic stroke (IS), attributed to blood vessel blockage, preventing the flow of blood to brain, acts as the most common form of stroke. Thus far, thrombolytic therapy is the only clinical treatment for IS with the approval from the FDA. Moreover, the physiology barrier complicates therapeutically and diagnostically related intervention development of IS. Accordingly, developing efficient and powerful curative approaches for IS diagnosis and treatment is urgently required. The advent of nanotechnology has brought dawn and hope to better curative and imaging forms for the management of IS. This work reviews the recent advances and challenges correlated with the nano drug delivery system for IS therapy and diagnosis. The overview of the current knowledge of the important molecular pathological mechanisms in cerebral ischemia and how the drugs cross the blood brain barrier will also be briefly summarized.

Citing Articles

Tungsten-based polyoxometalate nanoclusters as ferroptosis inhibitors modulating S100A8/A9-mediated iron metabolism pathway for managing intracerebral haemorrhage.

Yang Y, Lv M, Liu R, Yu P, Shen Z, Bai D J Nanobiotechnology. 2025; 23(1):122.

PMID: 39972331 PMC: 11837349. DOI: 10.1186/s12951-025-03149-9.

Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system.

Luo Q, Yang J, Yang M, Wang Y, Liu Y, Liu J Mater Today Bio. 2025; 31:101457.

PMID: 39896289 PMC: 11786670. DOI: 10.1016/j.mtbio.2025.101457.

Role of Nanotechnology in Ischemic Stroke: Advancements in Targeted Therapies and Diagnostics for Enhanced Clinical Outcomes.

Yadav V, Gupta R, Assiri A, Uddin J, Ishaqui A, Kumar P J Funct Biomater. 2025; 16(1).

PMID: 39852564 PMC: 11766075. DOI: 10.3390/jfb16010008.

The role of nanomaterials in revolutionizing ischemic stroke treatment: Current trends and future prospects.

Wang Y, Che H, Qu L, Lu X, Dong M, Sun B iScience. 2024; 27(12):111373.

PMID: 39669428 PMC: 11634991. DOI: 10.1016/j.isci.2024.111373.

Reactive Oxygen Species-Responsive Chitosan-Bilirubin Nanoparticles Loaded with Statin for Treatment of Cerebral Ischemia.

Raveena Nagareddy , Kim J, Kim J, Thomas R, Choi K, Jeong Y Biomater Res. 2024; 28:0097.

PMID: 39450150 PMC: 11499631. DOI: 10.34133/bmr.0097.

References

Wang T, Hou Y, Bu B, Wang W, Ma T, Liu C . Timely Visualization of the Collaterals Formed during Acute Ischemic Stroke with Fe O Nanoparticle-based MR Imaging Probe. Small. 2018; 14(23):e1800573. DOI: 10.1002/smll.201800573. View

Heid S, Unterweger H, Tietze R, Friedrich R, Weigel B, Cicha I . Synthesis and Characterization of Tissue Plasminogen Activator-Functionalized Superparamagnetic Iron Oxide Nanoparticles for Targeted Fibrin Clot Dissolution. Int J Mol Sci. 2017; 18(9). PMC: 5618486. DOI: 10.3390/ijms18091837. View

Hong H, Yang Y, Zhang Y, Cai W . Non-invasive cell tracking in cancer and cancer therapy. Curr Top Med Chem. 2010; 10(12):1237-48. PMC: 2916057. DOI: 10.2174/156802610791384234. View

Gao H, Pang Z, Jiang X . Targeted delivery of nano-therapeutics for major disorders of the central nervous system. Pharm Res. 2013; 30(10):2485-98. DOI: 10.1007/s11095-013-1122-4. View

Verma S, Arora I, Javed K, Akhtar M, Samim M . Enhancement in the Neuroprotective Power of Riluzole Against Cerebral Ischemia Using a Brain Targeted Drug Delivery Vehicle. ACS Appl Mater Interfaces. 2016; 8(30):19716-23. DOI: 10.1021/acsami.6b01776. View

Haensler J, Szoka Jr F . Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug Chem. 1993; 4(5):372-9. DOI: 10.1021/bc00023a012. View

Hadinoto K, Sundaresan A, Cheow W . Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Eur J Pharm Biopharm. 2013; 85(3 Pt A):427-43. DOI: 10.1016/j.ejpb.2013.07.002. View

Kakkar V, Muppu S, Chopra K, Kaur I . Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats. Eur J Pharm Biopharm. 2013; 85(3 Pt A):339-45. DOI: 10.1016/j.ejpb.2013.02.005. View

Santos S, Xavier M, M Leite D, Moreira D, Custodio B, Torrado M . PAMAM dendrimers: blood-brain barrier transport and neuronal uptake after focal brain ischemia. J Control Release. 2018; 291:65-79. DOI: 10.1016/j.jconrel.2018.10.006. View

10.

Gunawan S, Kempe K, Bonnard T, Cui J, Alt K, Law L . Multifunctional Thrombin-Activatable Polymer Capsules for Specific Targeting to Activated Platelets. Adv Mater. 2015; 27(35):5153-7. DOI: 10.1002/adma.201502243. View

11.

Cui C, Yang Z, Hu X, Wu J, Shou K, Ma H . Organic Semiconducting Nanoparticles as Efficient Photoacoustic Agents for Lightening Early Thrombus and Monitoring Thrombolysis in Living Mice. ACS Nano. 2017; 11(3):3298-3310. DOI: 10.1021/acsnano.7b00594. View

12.

Storkebaum E, Lambrechts D, Carmeliet P . VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays. 2004; 26(9):943-54. DOI: 10.1002/bies.20092. View

13.

Mouhieddine T, Itani M, Nokkari A, Ren C, Daoud G, Zeidan A . Nanotheragnostic applications for ischemic and hemorrhagic strokes: improved delivery for a better prognosis. Curr Neurol Neurosci Rep. 2014; 15(1):505. DOI: 10.1007/s11910-014-0505-1. View

14.

Liu Y, Ai K, Ji X, Askhatova D, Du R, Lu L . Comprehensive Insights into the Multi-Antioxidative Mechanisms of Melanin Nanoparticles and Their Application To Protect Brain from Injury in Ischemic Stroke. J Am Chem Soc. 2016; 139(2):856-862. PMC: 5752099. DOI: 10.1021/jacs.6b11013. View

15.

Mongin A . Disruption of ionic and cell volume homeostasis in cerebral ischemia: The perfect storm. Pathophysiology. 2007; 14(3-4):183-93. PMC: 2196404. DOI: 10.1016/j.pathophys.2007.09.009. View

16.

Bulte J, Kraitchman D . Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 2004; 17(7):484-99. DOI: 10.1002/nbm.924. View

17.

Jones M, Leroux J . Polymeric micelles - a new generation of colloidal drug carriers. Eur J Pharm Biopharm. 1999; 48(2):101-11. DOI: 10.1016/s0939-6411(99)00039-9. View

18.

Provenzale J, Silva G . Uses of nanoparticles for central nervous system imaging and therapy. AJNR Am J Neuroradiol. 2009; 30(7):1293-301. PMC: 7051551. DOI: 10.3174/ajnr.A1590. View

19.

Chen Z, Sandercock P, Pan H, Counsell C, Collins R, Liu L . Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke. 2000; 31(6):1240-9. DOI: 10.1161/01.str.31.6.1240. View

20.

Gronberg N, Johansen F, Kristiansen U, Hasseldam H . Leukocyte infiltration in experimental stroke. J Neuroinflammation. 2013; 10:115. PMC: 3852747. DOI: 10.1186/1742-2094-10-115. View